Physician profile
Michelle Bryan
NPI 1710093240
$1,444.59
in general payments reported to CMS, 2019-2025
9 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Clinical Nurse Specialist provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $267 · 2022: $281 · 2023: $287 · 2024: $186 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $676.18 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $195.76 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $166.62 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $127.77 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $90.27 | 2023-2024 | Xarelto |
| Pfizer INC. | $79.27 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $56.54 | 2021-2022 | |
| Irhythm Technologies, INC. | $40.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.